ZYBT Indikator likuiditas cepet Zhengye Biotechnology

Zhengye Biotechnology ensures China's food security by developing high-tech livestock vaccines. The business is currently focusing on expanding local drug production and developing regional distribution networks. The market dynamics of the asset with the 0.79 indicator are presented below. Zhengye Biotechnology relies on partnerships with agricultural holdings and veterinary clinics to jointly develop modern diagnostic systems and animal health protection tools.

Investors assess a business's margin of safety by its ability to instantaneously settle short-term liabilities without liquidating inventories. The leadership of Zhengye Biotechnology (ZYBT) in the veterinary vaccine sector, backed by state support, requires high capital mobility. Analyzing the level of absolute liquidity, we observe the ratio of cash and accounts receivable to current debts. The steady growth of this indicator confirms a low risk of cash flow gaps for this asset.